(NEU) NewMarket - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US6515871076
NEU: Lubricant Additives, Fuel Additives, Industrial Chemicals
NewMarket Corporation (NYSE:NEU) is a specialty chemicals company with a deep focus on petroleum additives. These additives are mission-critical for the performance and longevity of engines, transmissions, and industrial equipment. The company serves a wide range of industries, including automotive, trucking, aerospace, and manufacturing.
Their product portfolio is extensive. Lubricant additives are their core offering, designed to reduce wear and tear in metal-to-metal applications. This includes everything from passenger vehicle engine oils to heavy-duty diesel engines in ships and locomotives. Driveline additives are another key segment, ensuring smooth operation of transmissions, axles, and hydraulic systems. Industrial additives cover hydraulic fluids, greases, and specialty products like turbine oils. They also produce fuel additives that improve refining efficiency and fuel performance across gasoline, diesel, biofuels, and other energy products.
What makes NewMarket interesting is its diversified revenue streams. Beyond additives, they market antiknock compounds to improve fuel efficiency and reduce emissions. They also engage in contracted manufacturing and manage a real estate property in Virginia. This diversification reduces dependency on any single market or customer segment.
From a financial perspective, NewMarket is a mid-sized company with a market cap of ~$5 billion. The stock trades at a P/E of ~10.8, which is reasonable for a company with its stability and market position. The price-to-book ratio is 3.4, indicating that investors value its intangible assets and franchise more than just its book value. The price-to-sales ratio of 1.79 suggests a premium for its revenue quality and margins.
Geographically, NewMarket operates in over 30 countries, with a strong presence in North America, Latin America, Europe, and Asia. This global footprint provides diversification and exposure to growth markets. The company has been around since 1887, giving it a long history of adapting to industry changes and building deep customer relationships.
Additional Sources for NEU Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
NEU Stock Overview
Market Cap in USD | 5,430m |
Sector | Basic Materials |
Industry | Specialty Chemicals |
GiC Sub-Industry | Specialty Chemicals |
IPO / Inception | 1985-08-06 |
NEU Stock Ratings
Growth 5y | 26.1% |
Fundamental | 60.9% |
Dividend | 54.1% |
Rel. Strength Industry | -11.8 |
Analysts | - |
Fair Price Momentum | 507.82 USD |
Fair Price DCF | 860.16 USD |
NEU Dividends
Dividend Yield 12m | 1.84% |
Yield on Cost 5y | 2.75% |
Annual Growth 5y | 5.64% |
Payout Consistency | 77.2% |
NEU Growth Ratios
Growth Correlation 3m | 28.8% |
Growth Correlation 12m | -40.6% |
Growth Correlation 5y | 58.4% |
CAGR 5y | 8.49% |
CAGR/Max DD 5y | 0.25 |
Sharpe Ratio 12m | -0.55 |
Alpha | -20.57 |
Beta | 0.54 |
Volatility | 23.82% |
Current Volume | 63.2k |
Average Volume 20d | 44.2k |
As of March 07, 2025, the stock is trading at USD 545.99 with a total of 63,211 shares traded.
Over the past week, the price has changed by -0.84%, over one month by +10.14%, over three months by +3.34% and over the past year by -10.25%.
Yes, based on ValueRay Fundamental Analyses, NewMarket (NYSE:NEU) is currently (March 2025) a good stock to buy. It has a ValueRay Fundamental Rating of 60.88 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of NEU as of March 2025 is 507.82. This means that NEU is currently overvalued and has a potential downside of -6.99%.
NewMarket has no consensus analysts rating.
According to ValueRays Forecast Model, NEU NewMarket will be worth about 571.6 in March 2026. The stock is currently trading at 545.99. This means that the stock has a potential upside of +4.69%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 450 | -17.6% |
Analysts Target Price | 450 | -17.6% |
ValueRay Target Price | 571.6 | 4.7% |